Biochemical Data and Metabolic Profiles of Male Exclusive Narghile Smokers (ENSs) Compared With Apparently Healthy Nonsmokers (AHNSs)

American Journal of Men's Health
Yosra HasniHelmi Ben Saad

Abstract

Studies evaluating the metabolic profiles of ENSs are scarce and presented controversial conclusions. This study aimed to compare the metabolic profiles of ENSs' and AHNSs' groups. Males aged 25-45 years and free from a known history of metabolic and/or cardiovascular diseases were included. According to the smoking status, two groups of ENSs and AHNSs were identified. Body mass index (BMI, kg/m2), waist circumference (WC, cm), systolic and diastolic blood pressures (SBP, DBP, mmHg), fasting blood data in mmol/L (blood glycemia [FBG], triglycerides [TG], total cholesterol [TC], high- and low- density lipoprotein cholesterol [HDL-C, LDL-C]) and obesity status were evaluated. The metabolic syndrome (MetS) was defined according to the 2006 International Diabetes Federation (IDF) recommendations. Data were expressed as mean ± standard deviation ( SD) or percentages. Compared to the AHNSs' group ( n = 29), the ENSs' one ( n = 29) had (a) higher values of BMI (26.5 ± 2.3 vs. 28.2 ± 3.6), WC (95 ± 7 vs. 100 ± 10), and TG (1.22 ± 0.40 vs. 1.87 ± 0.85); and (b) included a lower percentage of males having low HDL-C (82.7% vs. 62.0%), and higher percentages of males having obesity (6.9% vs. 37.9%) or hypertriglyceridemia (10.7% vs. 51.7%)...Continue Reading

References

Oct 1, 1985·American Journal of Epidemiology·W S DaiB Wohlfahrt
Feb 19, 1998·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·M GanguliH H Dodge
Apr 26, 2003·Journal of Hypertension·Eoin O'BrienUNKNOWN European Society of Hypertension Working Group on Blood Pressure Monitoring
Jan 30, 2004·Diabetes, Obesity & Metabolism·A DzienM Lechleitner
Jun 15, 2006·Respirology : Official Journal of the Asian Pacific Society of Respirology·Sana S Al MutairiAlia Aisha Anwar
Mar 18, 2008·Journal of Athletic Training·Minsoo KangJae-Hyeon Park
Jul 31, 2012·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·L M GoffG S Frost
Aug 1, 2012·PloS One·Kashif ShafiqueIshtiaque Ahmad
Dec 10, 2013·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Kan SunLi Yan
Apr 9, 2014·International Archives of Medicine·Hafiz Muhammad AslamWardah Asif Qureshi
Jun 26, 2014·Public Health Nutrition·Zhi-Hong JianYung-Po Liaw
Aug 7, 2014·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Kenneth D WardWasim Maziak
Aug 19, 2014·Respiratory Medicine·Hisham M Bou FakhreddineNadim A Kanj
Feb 11, 2015·Tobacco Control·Ziad M El-ZaatariGhazi S Zaatari
May 23, 2015·Cardiovascular Drugs and Therapy·Yogita RochlaniJawahar L Mehta
Oct 16, 2015·Diabetology & Metabolic Syndrome·Fadoua GannarNabil Attia
Nov 8, 2017·Journal of Epidemiology and Global Health·Souheil HallitPascale Salameh
May 2, 2018·Diabetology & Metabolic Syndrome·Sara Saffar SoflaeiMajid Ghayour-Mobarhan
May 21, 2018·Diabetes & Metabolic Syndrome·Armindo Sousa RibeiroVicente Climent

❮ Previous
Next ❯

Citations

Aug 23, 2019·Environmental Science and Pollution Research International·Helmi Ben Saad
Mar 25, 2019·American Journal of Men's Health·Mehdi KhemissHelmi Ben Saad
Jun 19, 2019·Journal of Cardiovascular Development and Disease·Reem BaalbakiMarwan El Ghoch
May 26, 2021·Expert Review of Respiratory Medicine·Leila Triki, Helmi Ben Saad

❮ Previous
Next ❯

Software Mentioned

Statistica
Stat
Statistica Kernel

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.